Ambulatory Blood Pressure Monitoring Devices Market Report 2026

Ambulatory Blood Pressure Monitoring Devices Market Overview

• Ambulatory Blood Pressure Monitoring Devices market size has reached to $1.15 billion in 2025 • Expected to grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 11.3% • Growth Driver: Surge In Hypertension Fueling The Growth Of The Market Due To Rising Prevalence And Need For Continuous Blood Pressure Management • Market Trend: Tech Innovations Drive Real-time Patient Monitoring Advancements • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ambulatory Blood Pressure Monitoring Devices Market?

Ambulatory blood pressure monitoring (ABPM) devices are medical tools used to measure blood pressure continuously over 24 hours while the patient goes about their normal activities. These devices typically consist of a cuff and a digital recorder worn on the body. They provide more accurate and comprehensive blood pressure data compared to single-point measurements. ABPM is especially useful for diagnosing conditions like white-coat hypertension and nocturnal hypertension. The main product types of ambulatory blood pressure monitoring devices include automatic ABPM devices, manual ABPM devices, and specialized ABPM devices. Automatic ABPM devices refer to blood pressure monitors that automatically record blood pressure at regular intervals over 24 hours without manual intervention. The various types of device include ambulatory blood pressure monitor, home blood pressure monitor, hospital blood pressure monitor, wearable blood pressure monitor, and finger blood pressure monitor. There are used in hypertension management, cardiovascular disease monitoring, preoperative assessment, and postoperative monitoring, and are distributed through various channels such as direct sales, online retail, third-party distributors, and pharmacies. The key end uses include hospitals, homecare, prescription, and OTC.

What Is The Ambulatory Blood Pressure Monitoring Devices Market Growth Forecast?

The ambulatory blood pressure monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to technological advancements in wearable and smartphone-integrated devices, rising homecare adoption, increasing demand for automated abpm devices, expansion of remote patient monitoring solutions, integration with digital health platforms and telemedicine. Major trends in the forecast period include rising adoption of home-based blood pressure monitoring, integration of wearable and smartphone-enabled abpm devices, growing awareness of white-coat and nocturnal hypertension, expansion of preoperative and postoperative cardiovascular monitoring, increasing focus on continuous and remote patient monitoring.

Global Ambulatory Blood Pressure Monitoring Devices Market Segmentation

1) By Product Type: Automatic ABPM Devices, Manual ABPM Devices, Specialised ABPM Devices 2) By Device Type: Ambulatory Blood Pressure Monitor, Home Blood Pressure Monitor, Hospital Blood Pressure Monitor, Wearable Blood Pressure Monitor 3) By Applications: Hypertension Management, Cardiovascular Disease Monitoring, Preoperative Assessment, Postoperative Monitoring 4) By Distribution Channel: Direct Sales, Online Retail, Third-Party Distributors, Pharmacies 5) By End Use: Hospitals, Homecare, Prescription, OTC Subsegments: 1) By Automatic ABPM Devices: Upper Arm Automatic ABPM Devices, Wrist-Worn Automatic ABPM Devices, Bluetooth-Enabled Automatic ABPM Devices, Smartphone-Integrated ABPM Devices 2) By Manual ABPM Devices: Aneroid Manual ABPM Devices, Mercury-Based Manual ABPM Devices, Digital Readout Manual Devices (Semi-Automatic) 3) By Specialised ABPM Devices: Pediatric ABPM Devices, Geriatric ABPM Devices, Nocturnal ABPM Devices, Wearable Patch-Based ABPM Devices

What Is The Driver Of The Ambulatory Blood Pressure Monitoring Devices Market?

The increasing prevalence of hypertension is expected to propel the growth of the ambulatory blood pressure monitoring devices market going forward. Hypertension refers to a condition characterized by consistently high blood pressure levels in the arteries. The rise in prevalence of hypertension is driven by factors such as unhealthy diets, sedentary lifestyles, and increasing obesity rates. Ambulatory blood pressure monitoring devices help hypertension by providing continuous, accurate blood pressure readings throughout daily activities and sleep, enabling better diagnosis and personalized treatment management. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, hypertension affects 1 in 3 adults worldwide (around 1.3 billion), and increasing effective treatment coverage to 50% by 2025 could prevent 76 million deaths by 2050. Therefore, the increasing prevalence of hypertension is expected to propel the growth of the ambulatory blood pressure monitoring devices industry.

Key Players In The Global Ambulatory Blood Pressure Monitoring Devices Market

Major companies operating in the ambulatory blood pressure monitoring devices market are Koninklijke Philips NV, GE Healthcare Technologies Inc, Omron Healthcare Co Ltd, Hill Rom Holdings Inc, Halma plc, Spacelabs Healthcare Inc, Schiller Holding AG, Withings SA, Contec Medical Systems Co Ltd, BPL Medical Technologies Private Limited, Microlife AG, SunTech Medical Inc, Rossmax International Ltd, Rudolf Riester GmbH, iHealth Labs Inc, American Diagnostic Corporation, Bosch and Sohn GmbH and Co KG, A and D Medical, Welch Allyn Hill Rom, CardieX Limited

Global Ambulatory Blood Pressure Monitoring Devices Market Trends and Insights

Major companies are operating in the ambulatory surgical pressure monitoring devices market, focusing on developing technological advancements such as point-of-care devices to enhance real-time monitoring accuracy, improve patient comfort, and enable faster clinical decision-making. A point-of-care device is a medical tool used at or near the patient’s location to provide quick diagnostic or monitoring results without needing a centralized lab. For instance, in October 2024, Withings, a France-based digital health technology company, launched the BPM Pro 2, an advanced remote blood pressure monitoring device designed to improve real-world cardiovascular assessment. The device delivers accurate blood pressure measurements and supports built-in cellular, Wi-Fi, and Bluetooth connectivity, enabling real-time data sharing between patients and healthcare providers without the need for a smartphone. It features an integrated “Patient Insights” tool that collects symptom and lifestyle information after each reading, helping clinicians make faster and more informed decisions. The BPM Pro 2 also offers on-device guidance and retake prompts to ensure reliable measurements. Its user-friendly design enhances comfort and encourages consistent monitoring, supporting better detection and management of hypertension outside clinical settings.

What Are Latest Mergers And Acquisitions In The Ambulatory Blood Pressure Monitoring Devices Market?

In May 2025, Withings Health Solutions, a France-based provider of digital health devices and remote patient monitoring solutions, partnered with Babyscripts to enhance remote ambulatory blood pressure monitoring. With this partnership, the companies aim to improve early detection and management of hypertensive disorders of pregnancy, leveraging real-time data and patient-centered monitoring to reduce maternal morbidity and mortality. Babyscripts is a US-based provider of virtual maternity care programs that integrate digital devices and patient monitoring to support personalized prenatal care.

Regional Outlook

North America was the largest region in the ambulatory blood pressure monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Ambulatory Blood Pressure Monitoring Devices Market?

The ambulatory blood pressure monitoring devices market consists of revenues earned by entities by providing services such as tele monitoring services, clinical research support services, integration and it support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ambulatory blood pressure monitoring (abpm) devices market includes sales of bluetooth-enabled abpm devices, programmable abpm devices, and digital abpm devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.